Finance and markets: business, quotes, gold, energy and releases.
Found 44247 articles
London-based identity provider IDnow has achieved certification to issue Qualified Electronic Attestations of Attributes (QEAAs), providing a regulated pathway for businesses to verify customer data. The move addresses critical compliance hurdles as financial institutions scramble to meet stringent Anti-Money Laundering Regulation requirements ahead of the 2027 deadline.
PermRock Royalty Trust will distribute $265,001.53 to unit holders on September 15, 2026, following a June production cycle marked by shifting commodity prices. The distribution amounts to $0.021782 per Trust Unit, reflecting the net profits interest derived from operations in the Permian Basin of West Texas.
A 500,000-tonne capacity facility in Cheshire has hit its first fire on waste, marking a critical transition into final hot commissioning. Developed by METLEN for Encyclis, the plant now stands as a functional test of the company’s ability to navigate complex thermal energy infrastructure projects despite previous industry-wide supply chain pressures.
Investors will scrutinize the luxury conglomerate's financial trajectory on August 26, 2026, as Lanvin Group prepares to release its unaudited results for the first half of the year. The Shanghai-headquartered firm intends to pair the disclosure with a conference call addressing its performance and outlook for the second half.
More than 70,000 Ukrainians call the Chicago area home, a presence Cook County Treasurer Maria Pappas will recognize this Friday. Following the annual flag-raising ceremony at Daley Plaza, Pappas will host a reception at the County Building to celebrate the heritage and civic contributions of the local Ukrainian population.
Between product recalls and corporate expansion, the past week saw a surge of high-profile announcements. From Taco Bell’s nostalgia-driven menu to major shifts in the real estate and robotics sectors, these stories captured significant public and industry attention through the PR Newswire distribution network.
A 18.9% surge in gross merchandise volume helped Shanghai-based MRO platform ZKH Group Limited achieve its first-ever operating profit in the second quarter of 2026. The company reported a net profit of RMB 26.7 million, signaling a significant turnaround from the RMB 53.5 million loss recorded during the same period last year.
Robo.ai Inc. has appointed Wang Hao, senior executive officer at the UAE-based digital asset custodian Changer.ae, as an independent director. The move, effective immediately, places the veteran finance and technology expert on the company’s audit, compensation, and strategy committees as part of a broader push to strengthen corporate governance.
A plume of smoke signals the final push for the Protos Energy Recovery Facility in Cheshire, where METLEN has successfully ignited its first load of non-recyclable waste. This operational breakthrough marks the transition into hot commissioning for the site, which aims to convert residual household trash into baseload power.
A successful international Phase 3 trial in melanoma has vaulted personalized mRNA cancer therapies into the spotlight, prompting a surge in clinical validation across China. As domestic developers like Beijing-based Likang Life Sciences advance their pipelines, the industry is shifting focus from early research toward high-efficiency, individualized manufacturing.
Spanning 1,700 acres along the Kissimmee River, Westgate River Ranch has been tapped by Consumer365 as the premier 2026 destination for homeschooling families. The resort is gaining traction for its ability to weave academic concepts like biology, regional history, and agricultural science into traditional outdoor vacations.
The artist behind the iconic Sexy Robot series has severed his long-standing management agreement with Nanzuka Gallery to launch Sorayama Hajime Estate Co., Ltd. The newly formed entity now serves as the sole authority for his licensing, brand collaborations, and the management of his global artistic portfolio moving forward.
A 132% surge in sales for its lead drug Kangyueda pushed Keymed Biosciences into profitability during the first half of 2026. The Chengdu-based biotech reported RMB122 million in profit, a sharp reversal from previous losses, bolstered by milestone payments from AstraZeneca and a strengthening global drug pipeline.
Seoul-based skincare brand AXIS-Y is challenging industry standards by launching a recovery serum that replaces traditional salmon-derived PDRN with a plant-based alternative. The Triple PDRN Barrier Boost Serum utilizes DNA-inspired golden peptide threads to deliver concentrated nutrients, marking a shift toward high-performance vegan formulations in the competitive Korean beauty market.
China's National Medical Products Administration has accepted the New Drug Application for Opamtistomig, a bispecific antibody targeting PD-L1 and 4-1BB. Developed by Nanjing Leads Biolabs, the drug is positioned to become the world's first approved therapy of its kind, potentially establishing a new benchmark in immuno-oncology for aggressive tumors.
Investors who held ADMA Biologics shares between August 9, 2024, and March 25, 2026, are being urged to join a class action lawsuit. The litigation targets the company for alleged violations of the Securities Exchange Act, specifically concerning misleading statements regarding its financial health and sales practices.
Investors who purchased ADMA Biologics shares between August 9, 2024, and March 25, 2026, are being urged to join a class action lawsuit filed by Schall, Brown & Schwartz LLP. The litigation centers on claims that the company misled the market through undisclosed transactions and inflated revenue figures.
Investors who purchased Regeneron Pharmaceuticals shares between August 1, 2025, and May 15, 2026, face a critical deadline as a class action lawsuit moves forward. The DJS Law Group is currently organizing shareholders to address allegations that the company misled the public regarding the outcomes of its Phase III Fianlimab-Libtayo study.
Investors who purchased ZoomInfo Technologies stock between November 3, 2025, and May 11, 2026, face an August 24 deadline to join a class action lawsuit. The litigation alleges the company misled shareholders regarding the market trajectory and competitive viability of its AI-powered product suite.
Borussia Dortmund GmbH & Co. KGaA convenes its annual press conference in Germany today at 11:30 CET to present the preliminary financial figures for the 2025/2026 fiscal year. The session serves as the primary disclosure for stakeholders tracking the club's economic trajectory following the latest season.
Investors who purchased ZoomInfo Technologies Inc. stock between November 3, 2025, and May 11, 2026, face an August 24, 2026, deadline to seek lead plaintiff status. The class action lawsuit, filed by Schall, Brown & Schwartz LLP, alleges the company misled the market regarding its actual demand and product performance.
A class action lawsuit filed against Genius Group Limited accuses the company of orchestrating a spoofing scheme to artificially inflate market activity. Investors who purchased GNS shares between April 12, 2022, and May 30, 2025, now face an August 28, 2026, deadline to join the litigation seeking recovery for their losses.
Investors who purchased Genius Group Limited securities between April 12, 2022, and May 30, 2025, face an August 28, 2026, deadline to join a class action lawsuit. The litigation, spearheaded by the firm Schall Brown & Schwartz, targets the company for alleged market manipulation and securities law violations.
Investors who purchased Insulet Corporation securities between February 21, 2025, and May 26, 2026, face an August 31, 2026, deadline to join a class action lawsuit. The litigation, filed by Schall Brown & Schwartz, alleges the medical device company misled shareholders regarding manufacturing safety and product defects.
Investors who purchased Insulet Corporation stock between February 21, 2025, and May 26, 2026, are facing a deadline to join a class action lawsuit. The litigation alleges the company violated federal securities laws by issuing misleading statements regarding its internal manufacturing controls and product safety standards.
Investors who purchased Photronics, Inc. shares between December 10, 2025, and May 27, 2026, are facing a critical deadline to join a class action lawsuit. The DJS Law Group is currently organizing shareholders to address allegations that the company provided false and misleading financial forecasts during this period.
Shareholders who acquired Photronics, Inc. stock between December 10, 2025, and May 27, 2026, face a September 4, 2026, deadline to seek lead plaintiff status in a pending securities fraud lawsuit. The litigation targets alleged misrepresentations regarding the company’s internal growth projections and operational capacity.
Investors who purchased Planet Fitness shares between November 6, 2025, and May 6, 2026, are being urged to join a securities class action lawsuit. The filing alleges the gym operator misled the market regarding the effectiveness of its marketing campaigns and the implementation of its national Black Card price hikes.
Investors who purchased GPGI, Inc. shares between November 3, 2025, and May 6, 2026, face a critical September 15 deadline to join a class action lawsuit. The litigation targets alleged violations of the Securities Exchange Act, centering on claims that the company misled the market regarding its acquisition of Husky Technologies.
Investors who held DNOW Inc. shares as of August 5, 2025, have until October 2, 2026, to seek lead plaintiff status in a class action lawsuit. The litigation targets alleged misrepresentations regarding integration hurdles following the company’s merger with MRC Global Inc. that impacted shareholder value.